Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06631079 |
| Title | Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | NEC Bio B.V |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | LTU | ESP | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Charité | Berlin | Germany | Details | |||
| NCT | Heidelberg | Germany | Details | |||
| Comprehensive Cancer Center | Munich | Germany | Details | |||
| National Cancer Center | Vilnius | Lithuania | Details | |||
| Institut Catala d'Oncologia | Barcelona | Spain | Details | |||
| Vall d'Hebron | Barcelona | Spain | Details | |||
| Fundacion Jimenez Diaz | Madrid | Spain | Details | |||
| CHUS Santiago de Compostela | Santiago de Compostela | Spain | Details |